Venous Stents Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

The Venous Stents market is segmented by Application (Leg, Chest, Abdomen, Arm), by Disease and by Geography.

Market Snapshot

CAGR
Study Period: 2018 - 2026
Base Year: 2020
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 9.8 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The venous stents market studied was projected to grow with a CAGR of nearly 9.8% over the forecast period. The major factor attributing to the growth of the market is the rising incidence of chronic symptomatic venous diseases like chronic deep vein thrombosis, Post-thrombotic syndrome, May-Thurner syndrome, Nutcracker syndrome, Hemodialysis/arteriovenous fistulae, etc. 

According to the Centers for Disease Control and Prevention, 60,000-100,000 Americans die from deep vein thrombosis, every year. As per the statistics, there is a significant rise in the patient pool which is expected to boost the market growth. The other important factor propelling the market growth is the increasing geriatric population who are prone to such diseases. 

However, the lack of awareness of the venous stents and the high cost of stenting are major drawbacks for market growth.

Scope of the Report

Aa per the scope of the report venous stents are mesh tubes, inserted in the veins for chronic symptomatic venous diseases. They expand against the narrowed or obstructed veins and keep them open.  This report is segmented by Application, by Disease, and by Geography.

By Application
Leg
Chest
Abdomen
Others
By Disease
Chronic Deep Vein Thrombosis
Post Thrombotic Syndrome
Others
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa
GCC
South Africa
Rest of Middle East and Africa
South America
Brazil
Argentina
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

Leg Segment Application is expected to Dominate the Market Share

  • Deep Vein Thrombosis is a blood clot in one of the large, deep veins that returns blood from the leg, and very rarely in the arm, heart.
  • Legs application segment surfaced as the frontrunner in the global venous stents market. This increased growth can be credited to factors such as the increasing prevalence of the Deep Vein Thrombosis and the increasing geriatric population. According to the United Nations, the global population aged 60 years or over, numbered 962 million in 2017 and is expected to double by 2050, when it is projected to reach approximately 2.1 billion. The increasing patient pool and geriatric population increase market growth.
Venous Stents Market

North America Dominates the Market and Expected to do Same in the Forecast Period

North America is expected to dominate the overall venous stents market, throughout the forecast period. The largest share is mainly due to the presence of key players and their usage of advanced medical technologies to develop products. Furthermore, established healthcare infrastructure, and high investments for healthcare are some of the key factors accountable for its large share in the market. Furthermore, beneficial government initiatives and an increase in the number of research partnerships are some of the drivers expected to increase market growth.

Venous Stents Market

Competitive Landscape

The venous stents market is highly competitive and consists of a few major players. Some of the companies which are currently dominating the market are Boston Scientific Corporation, Becton, Dickinson and Company., Gore Medical, Cook Medical, and Optimed Medizinische Instrumente GmBH.

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Rising Prevalence of Chronic Symptomatic Venous Diseases

      2. 4.2.2 Increasing Geriatric Population

    3. 4.3 Market Restraints

      1. 4.3.1 High Cost of the Treatment and Lack of Awareness

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Application

      1. 5.1.1 Leg

      2. 5.1.2 Chest

      3. 5.1.3 Abdomen

      4. 5.1.4 Others

    2. 5.2 By Disease

      1. 5.2.1 Chronic Deep Vein Thrombosis

      2. 5.2.2 Post Thrombotic Syndrome

      3. 5.2.3 Others

    3. 5.3 Geography

      1. 5.3.1 North America

        1. 5.3.1.1 United States

        2. 5.3.1.2 Canada

        3. 5.3.1.3 Mexico

      2. 5.3.2 Europe

        1. 5.3.2.1 Germany

        2. 5.3.2.2 United Kingdom

        3. 5.3.2.3 France

        4. 5.3.2.4 Italy

        5. 5.3.2.5 Spain

        6. 5.3.2.6 Rest of Europe

      3. 5.3.3 Asia Pacific

        1. 5.3.3.1 China

        2. 5.3.3.2 Japan

        3. 5.3.3.3 India

        4. 5.3.3.4 Australia

        5. 5.3.3.5 South Korea

        6. 5.3.3.6 Rest of Asia-Pacific

      4. 5.3.4 Middle East and Africa

        1. 5.3.4.1 GCC

        2. 5.3.4.2 South Africa

        3. 5.3.4.3 Rest of Middle East and Africa

      5. 5.3.5 South America

        1. 5.3.5.1 Brazil

        2. 5.3.5.2 Argentina

        3. 5.3.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Boston Scientific Corporation

      2. 6.1.2 Becton, Dickinson and Company

      3. 6.1.3 Gore Medical

      4. 6.1.4 Cook Medical

      5. 6.1.5 Optimed Medizinische Instrumente GmBH

      6. 6.1.6 Medtronic Plc

      7. 6.1.7 Medica Germany GMBH & Co. KG

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Venous Stents Market market is studied from 2018 - 2026.

The Venous Stents Market is growing at a CAGR of 9.8% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2020.

Boston Scientific Corporation, Becton, Dickinson and Company, Gore Medical, Cook Medical, Optimed Medizinische Instrumente GmBH are the major companies operating in Venous Stents Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!